About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 151509, 9 pages
http://dx.doi.org/10.1155/2013/151509
Review Article

Topical Promethazine Side Effects: Our Experience and Review of the Literature

1Department of Dermatology and Plastic Surgery, University “Sapienza” of Rome, Viale del Policlinico 155, 00161 Rome, Italy
2Section of Legal Medicine, Department of Anatomical, Histological, Medical Legal and Locomotive System Sciences, University of Rome “Sapienza”, Viale Regina Elena 336, 00161 Rome, Italy

Received 1 May 2013; Revised 19 August 2013; Accepted 24 September 2013

Academic Editor: Ronald E. Baynes

Copyright © 2013 C. Cantisani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Patel and G. Yosipovitch, “The management of chronic pruritus in the elderly,” Skin Therapy Letter, vol. 15, no. 8, pp. 5–9, 2010. View at Scopus
  2. D. A. Khan and R. Solensky, “Drug allergy,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, pp. S126–S137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. H. A. Ashmawi, L. M. Braun, A. M. Sousa, and I. D. P. Posso, “Analgesic effects of H1 receptor antagonists in the rat model of formalin-induced pain,” Revista Brasileira de Anestesiologia, vol. 59, no. 4, pp. 461–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Danarti, F. Waskito, and N. Indrastuti, “Onset and duration of action of topical antihistamine: a study of histamine skin test response,” International Journal of Dermatology, vol. 47, no. 8, pp. 861–863, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Yanai, “Anticholinergic activity of antihistamines,” Clinical Neurophysiology, vol. 123, no. 4, pp. 633–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tarkkila, K. Torn, M. Tuominen, and L. Lindgren, “Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine,” Acta Anaesthesiologica Scandinavica, vol. 39, no. 7, pp. 983–986, 1995. View at Scopus
  7. E. R. Scherl and J. F. Wilson, “Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine,” Headache, vol. 35, no. 5, pp. 256–259, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. A. U. Buzdar, L. Esparza, R. Natale et al., “Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine: a placebo-controlled study,” American Journal of Clinical Oncology, vol. 17, no. 5, pp. 417–421, 1994. View at Scopus
  9. J. R. Lackner and A. Graybiel, “Use of promethazine to hasten adaptation to provocative motion,” Journal of Clinical Pharmacology, vol. 34, no. 6, pp. 644–648, 1994. View at Scopus
  10. T. E. Terndrup, D. J. Dire, C. M. Madden, H. Davis, R. M. Cantor, and D. P. Gavula, “A prospective analysis of intramuscular meperidine, promethazine, and chlorpromazine in pediatric emergency department patients,” Annals of Emergency Medicine, vol. 20, no. 1, pp. 31–35, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. T. K. Lin, M. Q. Man, J. L. Santiago et al., “Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function,” Journal of Investigative Dermatology, vol. 133, no. 2, pp. 469–478, 2013.
  12. S. Ljubojević and J. Lipozencić, “Reactions to insect stings and bites,” Acta Medica Croatica, vol. 65, no. 2, pp. 137–139, 2011.
  13. B. Blaya, F. Nicolau-Galmés, S. M. Jangi et al., “Histamine and histamine receptor antagonists in cancer biology,” Inflammation and Allergy—Drug Targets, vol. 9, no. 3, pp. 146–157, 2010. View at Scopus
  14. C. Vidal Pan, A. González Quintela, P. Galdos Anuncibay, and J. Mateo Vic, “Topical promethazine intoxication,” Current Medical Research and Opinion, vol. 28, no. 4, pp. 623–642, 2012.
  15. K. Yanai, “Anticholinergic activity of antihistamines,” Clinical Neurophysiology, vol. 123, no. 4, pp. 633–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. X.-C. Wang, J.-G. Hong, and X.-Q. Yang, “Discussions on the use of promethazine,” Chinese Journal of Pediatrics, vol. 48, no. 7, pp. 557–558, 2010. View at Scopus
  17. “Promethazine should not be used for infants,” Pharmazie, vol. 65, no. 5, pp. 339–342, 2010.
  18. K. A. J. Al Khaja, T. M. Al Ansari, A. H. H. Damanhori, and R. P. Sequeira, “Evaluation of drug utilization and prescribing errors in infants: a primary care prescription-based study,” Health Policy, vol. 81, no. 2-3, pp. 350–357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. R. Cohen, “Frequency and severity of promethazine adverse event reports obligated the ISMP alert,” Joint Commission Journal on Quality and Patient Safety, vol. 36, no. 3, pp. 143–144, 2010. View at Scopus
  20. J. Lazarou, B. H. Pomeranz, and P. N. Corey, “Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies,” Journal of the American Medical Association, vol. 279, no. 15, pp. 1200–1205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. T. K. Gandhi, S. N. Weingart, J. Borus et al., “Adverse drug events in ambulatory care,” The New England Journal of Medicine, vol. 348, no. 16, pp. 1556–1564, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Vervloet and S. Durham, “ABC of allergies: adverse reactions to drugs,” British Medical Journal, vol. 316, no. 7143, pp. 1511–1514, 1998. View at Scopus
  23. L. M. Sylvia, “Drug allergy, pseudoallergy, and cutaneous diseases,” in Drug-Induced Diseases: Prevention, Detection, and Management, J. E. Tisdale and D. A. Miller, Eds., American Society of Health-System Pharmacists, Bethesda, Md, USA, 2nd edition, 2010.
  24. Y. Kai, O. Okamoto, and S. Fujiwara, “Fixed drug eruption caused by three unrelated drugs: promethazine, pethidine and omeprazole,” Clinical and Experimental Dermatology, vol. 36, no. 7, pp. 755–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. R. Cohen, “Frequency and severity of promethazine adverse event reports obligated the ISMP alert,” Joint Commission Journal on Quality and Patient Safety, vol. 36, no. 3, pp. 143–144, 2010. View at Scopus
  26. V. Palop, C. Pastor, E. Rubio, and I. Martinez-Mir, “Topical antihistamines: is their use justified?” Atencion Primaria, vol. 18, no. 1, pp. 47–48, 1996. View at Scopus
  27. M. A. Riedl and A. M. Casillas, “Adverse drug reactions: types and treatment options,” American Family Physician, vol. 68, no. 9, pp. 1781–1790, 2003. View at Scopus
  28. P. G. H. Gell and R. R. A. Coombs, Clinical Aspects of Immunology, Blackwell Scientific, Oxford, UK, 3rd edition, 1975.
  29. W. J. Pichler, “Delayed drug hypersensitivity reactions,” Annals of Internal Medicine, vol. 139, no. 8, pp. 683–I46, 2003. View at Scopus
  30. S. J. Posadas and W. J. Pichler, “Delayed drug hypersensitivity reactions—new concepts,” Clinical and Experimental Allergy, vol. 37, no. 7, pp. 989–999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. S. Friedmann and M. Ardern-Jones, “Patch testing in drug allergy,” Current Opinion in Allergy and Clinical Immunology, vol. 10, pp. 291–296, 2010.
  32. B. Schnyder, “Approach to the patient with drug allergy,” Immunology and Allergy Clinics of North America, vol. 29, pp. 405–418, 2009.
  33. P. Barranco and M. C. López-Serrano, “General and epidemiological aspects of allergic drug reactions,” Clinical and Experimental Allergy, vol. 28, supplement 4, pp. 61–62, 1998. View at Scopus
  34. N. F. Adkinson, “Risk factors for drug allergy,” Journal of Allergy and Clinical Immunology, vol. 74, no. 4, pp. 567–572, 1984. View at Scopus
  35. M. Pirmohamed and B. K. Park, “Adverse drug reactions: back to the future,” British Journal of Clinical Pharmacology, vol. 55, no. 5, pp. 486–492, 2003. View at Publisher · View at Google Scholar
  36. M. Hindsén, M. Isaksson, L. Persson, E. Zimersson, and M. Bruze, “Photoallergic contact dermatitis from ketoprofen induced by drug-contaminated personal objects,” Journal of the American Academy of Dermatology, vol. 50, no. 2, pp. 215–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. C. J. Le Coz, A. Bottlaender, J.-N. Scrivener et al., “Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients,” Contact Dermatitis, vol. 38, no. 5, pp. 245–252, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Mirakian, P. W. Ewan, S. R. Durham et al., “BSACI guidelines for the management of drug allergy,” Clinical and Experimental Allergy, vol. 39, no. 1, pp. 43–61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Barbaud, “Drug patch testing in systemic cutaneous drug allergy,” Toxicology, vol. 209, no. 2, pp. 209–216, 2005. View at Publisher · View at Google Scholar · View at Scopus